首页> 外文期刊>Pharmacology, Biochemistry and Behavior >Relative potency of the opioid antagonists naloxone and 6-alpha-naloxol to precipitate withdrawal from acute morphine dependence varies with time post-antagonist.
【24h】

Relative potency of the opioid antagonists naloxone and 6-alpha-naloxol to precipitate withdrawal from acute morphine dependence varies with time post-antagonist.

机译:阿片类药物拮抗剂纳洛酮和6-α-纳洛索从急性吗啡依赖性药物中引起戒断的相对能力随拮抗剂后的时间而变化。

获取原文
获取原文并翻译 | 示例
           

摘要

The current study compared the potency of naloxone versus 6-alpha-naloxol to precipitate opioid withdrawal under varying conditions of morphine pretreatment history using suppression of operant responding for food reward as the index of withdrawal. Male Wistar rats trained to respond on a lever for food reward received pretreatment with either Vehicle (Morphine-Naive), a single subcutaneous (SC) injection of 5.6 mg/kg morphine (Single Morphine), or two morphine injections at 24 h intervals (Repeat Morphine), with varying doses of naloxone or 6-alpha-naloxol injected SC 4 h post-morphine and 5 min prior to the 30 min test session. When responding over the entire 30 min operant session was examined, naloxone was only 5-fold more potent than 6-alpha-naloxol in suppressing operant responding under Morphine Naive conditions, but this increased to a 65-fold potency difference after Single or Repeat Morphine pretreatment. Examination of the relative potency of these antagonists in the Early Phase of operant testing (5-15 min post-antagonist) revealed an even greater 100-fold potency difference between naloxone and 6-alpha-naloxol, but in the Late Phase of testing (25-35 min post-antagonist), this had declined to a 9-fold potency difference, comparable to the relative potency of naloxone to 6-alpha-naloxol under Morphine-Naive conditions. The results confirm a differential potency of naloxone to its reduced conjugate 6-alpha-naloxol in vivo, and extend the observation of this phenomenon to an acute (single) pretreatment with a low dose of morphine and an additional sign of opioid withdrawal to those previously used. However, the results also indicate that delay in onset of action of 6-alpha-naloxol at opioid receptors in the central nervous system may contribute significantly to its reduced potency relative to naloxone under certain morphine pretreatment conditions.
机译:目前的研究比较了纳洛酮与6-α-纳洛索在不同吗啡预处理史条件下以抑制操作者对食物报酬的反应作为戒断指标的情况下促成阿片类药物戒断的能力。经过训练可以对食物奖励做出反应的雄性Wistar大鼠接受了媒介物(未接受吗啡),单次皮下(SC)注射5.6 mg / kg吗啡(单次吗啡)或以24小时间隔两次注射吗啡的预处理(重复吗啡),在吗啡后4小时和30分钟测试前5分钟,以不同剂量的纳洛酮或6-α-纳洛索注射。在整个30分钟的操作过程中检查响应时,纳洛酮在抑制吗啡天真条件下的操作员响应时,效力仅比6-α-纳洛索高5倍,但在单次或重复使用吗啡后,其效价差异增加到65倍预处理。在操作试验的早期阶段(拮抗剂后5-15分钟)检查这些拮抗剂的相对效能,发现纳洛酮和6-α-纳洛索之间的效能差异甚至更大,但在试验后期( (在拮抗剂后25-35分钟),效力下降到9倍,相当于在吗啡未处理的条件下纳洛酮对6-α-纳洛索的相对效力。结果证实了纳洛酮在体内对其还原的共轭6-α-纳洛索具有不同的效力,并将这一现象的观察范围扩展到了低剂量吗啡的急性(单次)预处理以及阿片类药物戒断的其他征象用过的。然而,该结果还表明,在某些吗啡预处理条件下,相对于纳洛酮,中枢神经系统中阿片受体对6-α-纳洛索的作用延迟可能是其作用力下降的重要原因。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号